Cargando…
Berberine as a Potential Agent for the Treatment of Colorectal Cancer
Colorectal cancer (CRC) is one of the most commonly diagnosed and deadly malignancies worldwide. The incidence of CRC has been increasing, especially in young people. Although great advances have been made in managing CRC, the prognosis is unfavorable. Numerous studies have shown that berberine (BBR...
Autores principales: | Jiang, Xi, Jiang, Zhongxiu, Jiang, Min, Sun, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096113/ https://www.ncbi.nlm.nih.gov/pubmed/35572960 http://dx.doi.org/10.3389/fmed.2022.886996 |
Ejemplares similares
-
Cholecystectomy promotes the development of colorectal cancer by the alternation of bile acid metabolism and the gut microbiota
por: Jiang, Xi, et al.
Publicado: (2022) -
Berberine as a potential agent for breast cancer therapy
por: Zhong, Xiao-Dan, et al.
Publicado: (2022) -
Chemoproteomics reveals berberine directly binds to PKM2 to inhibit the progression of colorectal cancer
por: Yan, Shi-Hai, et al.
Publicado: (2022) -
Therapeutic potential of berberine against neurodegenerative diseases
por: JIANG, WenXiao, et al.
Publicado: (2015) -
Berberine as a Potential Anticancer Agent: A Comprehensive Review
por: Rauf, Abdur, et al.
Publicado: (2021)